First, the bad news: More American adults have hypertension (high blood pressure) and prehypertension than ever before.
Now, the good news: The percentage of those getting treated for and controlling high blood pressure has also increased. As a result, even the bad news has a good news aspect: more people are living with rather than dying […]

An early
proof-of-concept study presented shows promising results for imatinib
mesylate in the treatment of pulmonary arterial hypertension (PAH), a
severe, incurable blood vessel disorder.
Preliminary findings from a 59-patient, multi-center Phase II clinical
trial suggest imatinib mesylate provides a treatment benefit, as
demonstrated by a significant improvement in pulmonary vascular

Data from a new study suggests that individuals who engage in compassion meditation may benefit by reductions in inflammatory and behavioral responses to stress that have been linked to depression and a number of medical illnesses. The study’s findings are published online at and in the medical journal Psychoneuroendocrinology.
"While much attention has been paid […]

Women who smoke are at greater risk of developing major depressive disorder, according to new research published in the October issue of the British Journal of Psychiatry.
Researchers from the University of Melbourne studied a group of women in Australia, who had been followed for a decade as part of the Geelong Osteoporosis Study.
The results of […]

Neuronetics, Inc., a
privately-held medical device company and a leader in the field of
neuromodulation, announced today that the U.S. Food and Drug Administration
(FDA) has cleared its NeuroStar TMS (Transcranial Magnetic Stimulation)
Therapy system for the treatment of depression. NeuroStar TMS Therapy(R) is
specifically